Anthony Vuoto - 07 Dec 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ Anthony Vuoto
Issuer symbol
IRMD
Transactions as of
07 Dec 2022
Net transactions value
$0
Form type
4
Filing time
08 Dec 2022, 17:24:28 UTC
Previous filing
06 Dec 2022
Next filing
13 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +2,037 +14% 16,158 07 Dec 2022 Direct F1
transaction IRMD Common Stock Options Exercise +1,035 +6.4% 17,193 07 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -2,037 -100% $0.000000* 0 07 Dec 2022 Common Stock 2,037 Direct F1, F3
transaction IRMD Restricted Stock Units Options Exercise $0 -1,035 -50% $0.000000 1,036 07 Dec 2022 Common Stock 1,035 Direct F1, F4
transaction IRMD Restricted Stock Units Award $0 +3,501 +338% $0.000000 4,537 07 Dec 2022 Common Stock 3,501 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
F3 The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F4 On December 7, 2021, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F5 On December 7, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.